Skeletal-related events and mortality among older men with advanced prostate cancer

ACS, 2013 Droz, 2010, Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology, BJU Int, 106, 462, 10.1111/j.1464-410X.2010.09334.x ACS Schulman, 2007, Economic burden of metastatic bone disease in the U.S, Cancer, 109, 2334, 10.1002/cncr.22678 Coleman, 2006, Clinical features of metastatic bone disease and risk of skeletal morbidity, Clin Cancer Res, 12, 6243s, 10.1158/1078-0432.CCR-06-0931 Norgaard, 2010, Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007), J Urol, 184, 162, 10.1016/j.juro.2010.03.034 Saad, 2004, Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care, Eur Urol, 46, 731, 10.1016/j.eururo.2004.08.016 Weinfurt, 2005, The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer, Ann Oncol, 16, 579, 10.1093/annonc/mdi122 Damber, 2008, Prostate cancer, Lancet, 371, 1710, 10.1016/S0140-6736(08)60729-1 Oefelein, 2002, Skeletal fractures negatively correlate with overall survival in men with prostate cancer, J Urol, 168, 1005, 10.1016/S0022-5347(05)64561-2 Saad, 2007, Pathologic fractures correlate with reduced survival in patients with malignant bone disease, Cancer, 110, 1860, 10.1002/cncr.22991 Sathiakumar, 2011, Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999–2006, Prostate Cancer Prostatic Dis, 14, 177, 10.1038/pcan.2011.7 AJCC, 1988 AJCC, 2002 Curtis, 2009, Identification and validation of vertebral compression fractures using administrative claims data, Med Care, 47, 69, 10.1097/MLR.0b013e3181808c05 Lix, 2012, Osteoporosis-related fracture case definitions for population-based administrative data, BMC Public Health, 12, 301, 10.1186/1471-2458-12-301 Barlev, 2010, Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer, J Manag Care Pharm, 16, 693, 10.18553/jmcp.2010.16.9.693 Prentice, 1978, Regression analysis of grouped survival data with application to breast cancer data, Biometrics, 34, 57, 10.2307/2529588 Nieto, 1996, Adjusting survival curves for confounders: a review and a new method, Am J Epidemiol, 143, 1059, 10.1093/oxfordjournals.aje.a008670 Rosenbaum, 1983, The central role of the propensity score in observational studies for causal effects, Biometrika, 70, 41, 10.1093/biomet/70.1.41 Parsons, 2001, Reducing bias in a propensity score matched-pair sample using greedy matching techniques Giordano, 2008, Limits of observational data in determining outcomes from cancer therapy, Cancer, 112, 2456, 10.1002/cncr.23452 Shahinian, 2013, Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer, J Gen Intern Med, 28, 1440, 10.1007/s11606-013-2477-2 Morgans, 2012, Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy, Cancer, 119, 863, 10.1002/cncr.27830 Fizazi, 2011, Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study, Lancet, 377, 813, 10.1016/S0140-6736(10)62344-6